Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood Cancer Journal

Topics

Medicine

Cancer Oncology

Internal Medicine

Hematology

Gastroenterology

Show all topics

DOI

10.1038/s41408-024-01069-9

License

CC-BY

Other Formats

PDF